Climb Bio, Inc. (CLYM) Reports Q3 Loss of $0.13
Get Alerts CLYM Hot Sheet
Join SI Premium – FREE
Climb Bio, Inc. (NASDAQ: CLYM) reported Q3 EPS of ($0.13), versus $0.00 reported last year.
For earnings history and earnings-related data on Climb Bio, Inc. (CLYM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA Securities Starts APL Apollo Tubes Ltd (APAT:IN) at Buy
- UBS Upgrades Charoen Pokphand Foods (CPF:TB) to Buy
- JPMorgan Starts ERock Inc (EROC) at Overweight
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share